FDA.reportPublic FDA data

Kymbee 30 MG Oral Tablet

RxCUI
2725495
RxNorm name
Kymbee 30 MG Oral Tablet
Display name
Kymbee 30 MG Oral Tablet
Full name
Kymbee 30 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
KYMBEEDEFLAZACORTUpsher-Smith Laboratories, LLC89365f9f-a7ae-40d3-aecc-e4add75d21c22025-07-17Warnings, Adverse reactionsExact identifier
rxcui: 2725495

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
89365f9f-a7ae-40d3-aecc-e4add75d21c2KYMBEE 30 MG Oral Tablet [PSN] · deflazacort 30 MG Oral Tablet [Kymbee] [SBD] · Kymbee 30 MG Oral Tablet [SY]31HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KYMBEE safely and effectively. See full prescribing information for KYMBEE. KYMBEE TM (deflazacort) tablets, for oral use Initial U.S. Approval: 201720250717